How a 250-bed multispecialty hospital in North India ran Scale-tier ChatGPT Ads across 4 specialties in Q3-2026
The situation
Picture a 250-bed multispecialty hospital in a North Indian tier-1 city — the kind of institution that runs cardiology, oncology, orthopaedics and an IVF unit under one roof, each with its own head of department, its own patient volumes and its own idea of what "marketing" should deliver. The hospital's marketing team had run Google Ads for six years and Meta Ads for three. Both channels had plateaued: cost per qualified lead had crept up 40% over eighteen months as competing hospitals bid up the same keyword sets and the same lookalike audiences.
The trigger for looking at ChatGPT Ads wasn't novelty-seeking. It was a pattern the hospital's own analytics team had noticed — a growing share of referral-adjacent traffic (patients arriving already knowing which department they wanted, already carrying specific questions about procedures and second opinions) was showing up with no identifiable ad source. Server logs suggested a chunk of it originated from AI assistant referrers. The hospital didn't have a paid presence there at all; whatever traffic was arriving was organic citation, not sponsored placement.
The business problem, stated plainly by the hospital's CEO in the first scoping call, was this: four specialty lines, four different patient journeys, four different urgency profiles, and a marketing budget that Google and Meta were absorbing without proportional lift. Cardiology enquiries skewed toward second-opinion seekers already diagnosed elsewhere. Oncology enquiries were slower-moving and trust-sensitive. Orthopaedics ran on a mix of trauma urgency and elective-surgery research. IVF enquiries were the most compliance-sensitive of the four, governed by the ART Act in ways the other three weren't. A single blended campaign wasn't going to serve any of them well.
The ChatGPT Ads campaign structure ICG designed
ICG's starting decision was to run four independent conversation buckets rather than one hospital-wide campaign with specialty tags. Each specialty got its own bid ladder, its own creative set, its own landing infrastructure and its own compliance sign-off track. This is the core structural difference between a Growth-tier single-specialty ChatGPT Ads build and a Scale-tier multispecialty one — the tiers aren't just about spend, they're about how much independent machinery the account needs to run in parallel without one specialty's pacing decisions distorting another's.
Bidding on ChatGPT Ads doesn't work like a keyword auction. It pegs to where a user sits in their conversation, and the four specialties sat at very different points on that curve. Cardiology second-opinion queries were disproportionately late-intent — a user who has already been told they need a procedure and is now asking a conversational assistant to help them evaluate where to get it done arrives close to a decision. Those conversation-completion events were bid 8-10x higher than early-exploration queries in the same specialty. Oncology ran the opposite pattern: most conversations stayed in exploration mode for longer, meaning the bulk of spend sat in the cheaper early-stage tier, with a smaller high-value pool reserved for conversations that reached treatment-comparison intent. Orthopaedics split roughly evenly between trauma-driven late intent and elective-surgery early research. IVF, given the ART Act's restrictions on what can be promised or implied in advertising, was deliberately capped at early-to-mid intent stages — the account never bid aggressively to capture conversations that looked like they were converging on a specific outcome claim, because that's precisely the territory the compliance overlay restricts.
Landing infrastructure followed the same split. Each specialty got a dedicated, machine-scannable landing page — short factual paragraphs, cited claims, a clear single next action — because ChatGPT Ads traffic doesn't tolerate the dense, SEO-optimised long-form pages that rank well organically. A user arriving mid-conversation from a sponsored response wants confirmation, not a 3,000-word service page. ICG built four such pages, each routed to a specialty-specific enquiry form rather than a generic hospital contact form, because attribution accuracy depended on knowing which conversation bucket produced which lead.
Monthly reporting ran on conversation-attribution logic rather than click logic — a distinction the hospital's marketing team had to unlearn from six years of click-based Google Ads reporting. A "conversion" in this account meant a completed conversation that resolved into a stated intent (book a consultation, request a second opinion, ask about admission process), not a click on a link. This is Scale-tier's baseline reporting cadence: four separate specialty dashboards, reconciled monthly against the hospital's own CRM to confirm which conversation-attributed leads actually converted to appointments.
The compliance discipline
Four specialties meant four different compliance postures running simultaneously, and this is where a Scale-tier account earns its complexity. NMC Section 6 and ASCI Chapter III formed the baseline across all four lines — no outcome guarantees, no comparative superiority claims against named or implied competitors, no patient testimonials framed as advertising, no urgency language designed to pressure rather than inform. Every piece of ad copy across all four specialties was screened against this baseline before it went anywhere near the ChatGPT Ads platform.
The IVF line carried an additional layer under the ART (Regulation) Act 2021, which restricts how assisted reproductive services can be advertised — no success-rate claims presented without the mandated context, no framing that implies a guaranteed outcome, and specific restrictions on how sex-selection-adjacent language must never appear even indirectly. ICG's compliance review for the IVF bucket ran a stricter approval loop than the other three specialties: every ad variant went through a second reviewer specifically checking ART Act alignment before launch, and the conversation-stage bid cap mentioned earlier was itself a compliance decision as much as a budget one — deliberately not chasing the highest-intent conversations because those tend to be the ones where a user is fishing for an outcome promise the hospital legally cannot make.
Oncology copy was checked against DCGI/UCPMP 2024 guardrails even though the hospital itself wasn't advertising a specific drug — because conversational ad copy in oncology contexts routinely brushes up against treatment-modality claims that sit adjacent to pharmaceutical marketing rules, and ICG's practice is to apply that overlay defensively rather than assume it doesn't apply. DPDP 2023 governed how every specialty's enquiry form handled patient data from the first form field onward — explicit consent language, no data-sharing defaults, and a retention policy stated plainly rather than buried in a linked privacy page. None of this compliance work was visible to the hospital's marketing team in day-to-day reporting, but it was the reason zero ad variants across four specialties and ninety days needed a post-launch takedown.
The 90-day outcome pattern
In the pattern ICG has observed across comparable multispecialty Scale-tier accounts, the first 30 days ran quiet by design. ChatGPT Ads' conversation-completion attribution model needs a data-gathering window before bid ladders stabilise, and the four specialty buckets didn't reach steady-state pacing until roughly week four. Illustrative numbers for this hypothetical: combined conversation volume across all four specialties started around 40-50 completed conversations a week in month one, rising to 140-160 a week by month three as the bid ladders learned which conversation shapes converted.
Cost per qualified lead told the more interesting story. Cardiology, running mostly late-intent bidding, carried the highest per-conversation cost of the four but also the highest conversion-to-appointment rate — illustrative figures put it around 30-35% of attributed conversations converting to a booked consultation within 14 days, reflecting how far along those users already were. Oncology's cheaper early-stage bidding produced roughly 3x the conversation volume of cardiology at a lower per-conversation cost, but a longer, slower path to appointment — many of those conversations were trust-building rather than decision-stage, consistent with how oncology patients research. Orthopaedics landed in between. IVF, deliberately capped at lower intent stages for compliance reasons, produced the lowest raw conversion-to-appointment rate of the four but the highest downstream value once a lead did convert, since IVF consultations that proceed tend to become multi-cycle relationships.
Blended across all four specialties, the hospital's overall cost per qualified lead from the ChatGPT Ads bucket ran meaningfully below its blended Google Ads cost per lead by month three — in the range ICG has seen repeatedly, roughly 25-35% lower, though the hospital's marketing team was careful to note this reflected a channel still in its low-competition window rather than a permanent structural advantage. In GA4, this traffic aggregated under the AI Assistant channel, which — consistent with ICG's broader healthcare book — showed a key-event rate meaningfully higher than the hospital's organic search traffic and dramatically higher than its direct traffic, echoing the 10.49% figure ICG tracks across its healthcare accounts generally. Downstream, the hospital's CRM reconciliation showed roughly 70% of ChatGPT-Ads-attributed appointments actually showed up for their consultation, a no-show rate noticeably better than the hospital's Meta Ads leads over the same quarter — plausibly because conversation-completion attribution filters out low-intent clickers more effectively than a single ad click does.
What we'd do differently next time
Launching all four specialties simultaneously in week one, in retrospect, split compliance review bandwidth four ways at exactly the moment it needed to be concentrated on getting one bucket right and using that as a template. A staggered launch — cardiology first, two to three weeks of learning, then orthopaedics, then oncology, then IVF last given its stricter review loop — would have let each subsequent specialty's ad copy and bid ladder benefit from real conversation data rather than four parallel cold starts.
The hospital's marketing team also needed more onboarding time on conversation-attribution reporting than ICG initially budgeted. Six years of click-based thinking doesn't unlearn itself in one dashboard walkthrough, and the first month's reporting review ran long because the team kept asking for click-through-rate numbers that the platform simply doesn't surface in the same way. A dedicated attribution-model onboarding session before campaign launch, rather than folding it into the first monthly review, would have saved real friction.
Finally, the IVF bucket's conservative bid cap was the right compliance call but it meant that specialty underperformed on raw volume relative to what the hospital's IVF department head expected going in. Setting that expectation explicitly before launch — showing the department head the ART Act reasoning behind the bid ceiling, rather than letting the volume numbers speak for themselves in month one — would have avoided an uncomfortable mid-quarter conversation about why IVF's numbers lagged the other three specialties.
How this maps to your own specialty
If your hospital or clinic runs a single specialty line, the Growth-tier structure described in this account's cardiology bucket alone is closer to what you'd need — one conversation-stage bid ladder, one landing page, one compliance track, without the coordination overhead of running four in parallel. If you're a multispecialty institution weighing whether ChatGPT Ads is worth the added complexity of a Scale-tier build, the honest signal to look for is whether your specialties have genuinely different patient-intent profiles the way cardiology, oncology, orthopaedics and IVF did here. If your specialties largely share a patient journey, a simpler single-bucket structure may serve you better than the four-way split this hospital needed.
Whichever shape fits, the compliance overlay doesn't change — NMC Section 6 and ASCI Chapter III apply to every healthcare ChatGPT Ads account regardless of specialty, with sector-specific layers (ART Act for fertility, DCGI/UCPMP for pharma-adjacent messaging) stacked on top where relevant.
